scholarly article | Q13442814 |
P2093 | author name string | Wei Chen | |
Di Chen | |||
Jing Hong | |||
Mingchang Zhang | |||
Yan Shao | |||
Shunhua Zhang | |||
Jialiang Zhao | |||
Ailing Bian | |||
Yingping Deng | |||
P2860 | cites work | Association between symptoms and signs of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study | Q28246849 |
Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. | Q31775977 | ||
Grading Of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests | Q35542950 | ||
Sensitivity and reliability of objective image analysis compared to subjective grading of bulbar hyperaemia | Q36172041 | ||
The Ocular Redness Index: a novel automated method for measuring ocular injection | Q37037763 | ||
Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-analysis | Q38516740 | ||
TFOS DEWS II Clinical Trial Design Report | Q38652975 | ||
TFOS DEWS II Diagnostic Methodology report | Q38652978 | ||
TFOS DEWS II pathophysiology report | Q38652987 | ||
TFOS DEWS II Tear Film Report. | Q38652990 | ||
TFOS DEWS II Epidemiology Report | Q38652994 | ||
Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature | Q39151688 | ||
Prevalence of dry eye among adult Chinese in the Beijing Eye Study | Q39836983 | ||
Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group | Q41730611 | ||
A comparison of cyclosporine 0.05% ophthalmic emulsion versus vehicle in Chinese patients with moderate to severe dry eye disease: an eight-week, multicenter, randomized, double-blind, parallel-group trial | Q42941533 | ||
Prevalence of dry eye disease in Mongolians at high altitude in China: the Henan eye study | Q42966054 | ||
Topical cyclosporine 0.05% for the prevention of dry eye disease progression | Q43087530 | ||
Blood concentrations of cyclosporin a during long-term treatment with cyclosporin a ophthalmic emulsions in patients with moderate to severe dry eye disease | Q44206861 | ||
The lack of association between signs and symptoms in patients with dry eye disease | Q45122466 | ||
Prevalence and risk factors associated with dry eye syndrome among senior high school students in a county of Shandong Province, China | Q45129629 | ||
Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca | Q45190856 | ||
Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: formulation, in vitro and in vivo studies. | Q52598288 | ||
Evaluation of Reliability and Validity of Three Common Dry Eye Questionnaires in Chinese | Q58700419 | ||
Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes | Q73180482 | ||
Reliability and validity of the Ocular Surface Disease Index | Q73801624 | ||
Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine | Q77729873 | ||
P433 | issue | 31 | |
P921 | main subject | eye disease | Q3041498 |
placebo | Q269829 | ||
cyclosporine | Q367700 | ||
P304 | page(s) | e16710 | |
P577 | publication date | 2019-08-01 | |
P1433 | published in | Medicine (Barcelona) / Programa de Educación Médica Continuada (EMC) en medicina Asistencial | Q29044007 |
P1476 | title | Efficacy and safety of 0.05% cyclosporine ophthalmic emulsion in treatment of Chinese patients with moderate to severe dry eye disease: A 12-week, multicenter, randomized, double-masked, placebo-controlled phase III clinical study | |
P478 | volume | 98 |
Search more.